BROTAPP PE LIQUID
-
brompheniramine maleate and
phenylephrine hydrochloride liquid
Silarx Pharmaceuticals, Inc
----------
Brotapp PE Liquid
Active ingredients (in each 5 mL) Purpose
Brompheniramine maleate 1 mg . . . . . . . . . . . . . . . . . . . . . . . Antihistamine
Phenylephrine hydrochloride 2.5 mg . . . . . . . . . . . . . . . . . . . . Nasal Decongestant
Uses
Do not use in a child under 6 years of age
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have heart disease high blood pressure thyroid disease diabetes glaucoma trouble urinating due to an enlarged prostate gland breathing problem such as emphysema or chronic bronchitis
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Adults and children 12 years and over | 4 teaspoonfuls every 4 hours |
Children 6 to under 12 years | 2 teaspoonfuls every 4 hours |
Children under 6 years | DO NOT USE |
citric acid, FD&C blue no. 1, FD&C red no. 40, grape flavor, propylene glycol, saccharin sodium, sodium benzoate, sodium citrate, sorbitol, water.
888-974-5279
†This product is not manufactured or distributed by Wyeth Consumer Healthcare owner of the registered trademark Dimetapp®.
Manufactured by:
Silarx Pharmaceuticals, Inc
19 West Street
Spring Valley, NY 10977
USA
Rev. 3/09
BROTAPP PE LIQUID
brotapp pe liquid liquid |
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part341 | 04/05/2001 | 12/26/2007 |
Labeler - Silarx Pharmaceuticals, Inc (161630033) |